The pro-depressive effect of levodopa in a 6-OHDA-induced hemiparkinsonism rat model

The pro-depressive effect of levodopa in a 6-OHDA-induced hemiparkinsonism rat model

Rationale: Treatment of Parkinson's disease has been by now symptomatic. The literature on the efficacy and side effects of levodopa has been contradictory. Some authors mention an anti-depressant effect of the agent, while others believe that it is exactly levodopa that eventually induces the...

Full description

Bibliographic Details
Main Authors:	O. S. Karimova, A. Yu. Morozova, Ya. A. Zorkina, E. A. Zubkov, V. M. Ushakova, O. V. Abramova, V. P. Chekhonin
Format:	Article
Language:	Russian
Published:	MONIKI 2020-03-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	neurodegenerative disorders parkinson's disease 6-ohda levodopa
Online Access:	https://www.almclinmed.ru/jour/article/view/1235

Similar Items

Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease
by: Miguel M. Carvalho, et al.
Published: (2017-08-01)

Dynamics of levodopa-therapy in patients with Parkinson’s disease afterunilateral pallidotomy
by: V.I. Tsymbaliuk, et al.
Published: (2018-12-01)

Propolis as a Potential Disease-Modifying Strategy in Parkinson’s disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
by: Valeria C. Gonçalves, et al.
Published: (2020-05-01)

Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism
by: Masatoshi Ogawa, et al.
Published: (2019-12-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients
by: Manuela eMellone, et al.
Published: (2015-07-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Thrombocytopenia Associated with Levodopa Treatment
by: Ku-Eun Lee, et al.
Published: (2013-05-01)

Experience in using levodopa-benserazide
by: Elena Anatolyevna Katunina, et al.
Published: (2015-10-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

Levodopa for treatment of parkinson’s disease
by: M. Petraru, et al.
Published: (2011-09-01)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
by: Xiaoqin He, et al.
Published: (2022-01-01)

Levodopa-induced pseudopheochromocytoma
by: Joana Bernardino Cardoso, et al.
Published: (2023-05-01)

Effect of Rectal Levodopa Administration: A Case Report
by: Jolanda M.J. Vogelzang, et al.
Published: (2015-10-01)

A Flavonoid-Rich Extract of Mandarin Juice Counteracts 6-OHDA-Induced Oxidative Stress in SH-SY5Y Cells and Modulates Parkinson-Related Genes
by: Santa Cirmi, et al.
Published: (2021-03-01)

An updated calculator for determining levodopa-equivalent dose
by: D. Nyholm, et al.
Published: (2021-10-01)

The human experience with intravenous levodopa
by: Shan H Siddiqi, et al.
Published: (2016-01-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
by: Ana Gabrielle Bispo, et al.
Published: (2023-08-01)

Mathematical insights into the effects of levodopa
by: Michael C. Reed, et al.
Published: (2012-07-01)

An adverse drug interaction of haloperidol with levodopa
by: Jisha M Lucca, et al.
Published: (2015-01-01)

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
by: Ritam Bandopadhyay, et al.
Published: (2022-04-01)

Memantine inhibits 6-OHDA-induced apoptosis PC12 cells via the Nurr77 and caspase pathway
by: Wei Wu, et al.
Published: (2019-01-01)

Less Pulsatile Levodopa Therapy (6 Doses Daily) Is Associated with a Reduced Incidence of Dyskinesia
by: Mark M. Lin, et al.
Published: (2019-01-01)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
by: Daniël van Poppelen, et al.
Published: (2021-06-01)

Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
by: Dan Su, et al.
Published: (2023-07-01)

Neuroprotective effect of nicorandil in 6-OHDA induced in vitro model of parkinson's disease
by: Ufuk Okkay, et al.
Published: (2022-03-01)

Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
by: Sanju P Joy, et al.
Published: (2015-01-01)

Intranasal HSP70 administration protects against dopaminergic denervation and modulates neuroinflammatory response in the 6-OHDA rat model
by: Camila Tiefensee Ribeiro, et al.
Published: (2021-07-01)

Levodopa-Responsive Benign Tremulous Parkinsonism
by: Osamu Kano, et al.
Published: (2013-08-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Antrodia camphorata polysaccharide resists 6‐OHDA‐induced dopaminergic neuronal damage by inhibiting ROS‐NLRP3 activation
by: Chenyang Han, et al.
Published: (2020-11-01)

Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease
by: Mohammad Shabani, et al.
Published: (2023-08-01)

Sleepiness and Depression in Parkinson’s Disease Patients Treated with Ropinirole and Levodopa
by: Suk Yun Kang, et al.
Published: (2017-09-01)

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation
by: Yi ZM, et al.
Published: (2018-04-01)

A review of studies on gut microbiota and levodopa metabolism
by: Zhe Zhong, et al.
Published: (2023-06-01)

Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
by: K. Amande M. Pauls, et al.
Published: (2021-12-01)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
by: Kye Won Park, et al.
Published: (2020-09-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
by: Werner Poewe, et al.
Published: (2010-08-01)

Long-term Levodopa Treatment Accelerates the Circadian Rhythm Dysfunction in a 6-hydroxydopamine Rat Model of Parkinson's Disease
by: Si-Yue Li, et al.
Published: (2017-01-01)